KYNTRA BIO INC (KYNB) Stock Price & Overview
NASDAQ:KYNB • US31572Q8814
Current stock price
The current stock price of KYNB is 7.08 USD. Today KYNB is down by -1.26%. In the past month the price increased by 1.58%.
KYNB Key Statistics
- Market Cap
- 28.674M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -7.49
- Dividend Yield
- N/A
KYNB Stock Performance
KYNB Stock Chart
KYNB Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to KYNB.
KYNB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KYNB. KYNB may be in some trouble as it scores bad on both profitability and health.
KYNB Earnings
On March 16, 2026 KYNB reported an EPS of -3.61 and a revenue of 1.28M. The company beat EPS expectations (8.9% surprise) and missed revenue expectations (-12.1% surprise).
KYNB Forecast & Estimates
8 analysts have analysed KYNB and the average price target is 43.86 USD. This implies a price increase of 519.49% is expected in the next year compared to the current price of 7.08.
For the next year, analysts expect an EPS growth of -84.39% and a revenue growth -21.97% for KYNB
KYNB Groups
Sector & Classification
KYNB Financial Highlights
Over the last trailing twelve months KYNB reported a non-GAAP Earnings per Share(EPS) of -7.49. The EPS increased by 37.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2848.63% | ||
| ROA | 153.4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
KYNB Ownership
KYNB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.92 | 365.196B | ||
| AMGN | AMGEN INC | 15.32 | 188.577B | ||
| GILD | GILEAD SCIENCES INC | 15.73 | 172.567B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.59 | 111.931B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.92 | 78.916B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.79 | 44.163B | ||
| INSM | INSMED INC | N/A | 32.624B | ||
| NTRA | NATERA INC | N/A | 28.615B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 27.011B | ||
| BIIB | BIOGEN INC | 10.94 | 25.883B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.76 | 25.318B | ||
| MRNA | MODERNA INC | N/A | 20.099B | ||
| INCY | INCYTE CORP | 12.34 | 19.015B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About KYNB
Company Profile
The company is headquartered in San Francisco, California. The company went IPO on 2014-11-14.
Company Info
IPO: 2014-11-14
KYNTRA BIO INC
350 Bay Street, Suite 100 #6009
San Francisco CALIFORNIA US
Employees: 225
Phone: 14159781200
KYNTRA BIO INC / KYNB FAQ
What does KYNB do?
The company is headquartered in San Francisco, California. The company went IPO on 2014-11-14.
What is the current price of KYNB stock?
The current stock price of KYNB is 7.08 USD. The price decreased by -1.26% in the last trading session.
Does KYNB stock pay dividends?
KYNB does not pay a dividend.
What is the ChartMill rating of KYNTRA BIO INC stock?
KYNB has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of KYNTRA BIO INC (KYNB) based on its PE ratio?
KYNTRA BIO INC (KYNB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.49).
What is the market capitalization of KYNB stock?
KYNTRA BIO INC (KYNB) has a market capitalization of 28.67M USD. This makes KYNB a Nano Cap stock.
When does KYNTRA BIO INC (KYNB) report earnings?
KYNTRA BIO INC (KYNB) will report earnings on 2026-05-11, after the market close.